NEW YORK, Dec. 14, 2015 (GLOBE NEWSWIRE) -- Nasdaq (Nasdaq:NDAQ) today announced the results of the annual re-ranking of the NASDAQ Biotechnology Index (Nasdaq:NBI), which will become effective prior to market open on Monday, December 21, 2015.

The following 60 securities will be added to the Index:

NasdaqADHDAlcobra Ltd.
NasdaqADMSAdamas Pharmaceuticals, Inc
NasdaqADROAduro Biotech, Inc.
NasdaqAFMDAffimed N.V.
NasdaqAGTCApplied Genetic Technologies
NasdaqAMRNAmarin Corporation PLC
NasdaqANTHAnthera Pharmaceuticals, Inc.
NasdaqAQXPAquinox Pharmaceuticals, Inc.
NasdaqARDXArdelyx, Inc.
NasdaqARWRArrowhead Research Corp
NasdaqATRAAtara Biotherapeutics
NasdaqBLCMBellicum Pharmaceuticals
NasdaqBPMCBlueprint Medicines Corp
NasdaqCBPOChina Biologic Products, Inc.
NasdaqCHMAChiasma, Inc.
NasdaqCHRSCoherus BioSciences, Inc
NasdaqCOLLCollegium Pharmaceutical
NasdaqCRISCuris Inc
NasdaqCXRXConcordia Healthcare
NasdaqDBVTDBV Technologies S.A.
NasdaqDERMDermira, Inc.
NasdaqDNAIProNAi Therapeutics, Inc.
NasdaqDRNADicerna Pharmaceuticals Inc
NasdaqDRRXDURECT Corporation
NasdaqEGLTEgalet Corporation
NasdaqEGRXEagle Pharmaceuticals, Inc.
NasdaqESPREsperion Therapeutics
NasdaqFGENFibroGen, Inc.
NasdaqFLKSFlex Pharma, Inc.
NasdaqFLXNFlexion Therapeutics, Inc.
NasdaqFOMXFoamix Pharmaceuticals
NasdaqIMDZImmune Design Corp
NasdaqINCRINC Research Hldg
NasdaqITEKInotek Pharmaceuticals
NasdaqJUNOJuno Therapeutics, Inc.
NasdaqKMPHKemPharm, Inc.
NasdaqLBIOLion Biotech Inc
NasdaqLIFEaTyr Pharma, Inc.
NasdaqMCRBSeres Therapeutics
NasdaqNDRMNeuroDerm Ltd.
NasdaqNEOSNeos Therapeutics, Inc.
NasdaqNKNantKwest, Inc.
NasdaqNSTGNanoString Technologies
NasdaqOCULOcular Therapeutix, Inc.
NasdaqONCESpark Therapeutics, Inc.
NasdaqONTYOncothyreon Inc.
NasdaqOTICOtonomy, Inc.
NasdaqOVASOvaScience, Inc.
NasdaqPRAHPRA Health Sciences, Inc.
NasdaqQUREuniQure NV
NasdaqRIGLRigel Pharmaceuticals Inc
NasdaqTKAITokai Pharmaceuticals
NasdaqTLGTTeligent, Inc.
NasdaqTRVNTrevena, Inc.
NasdaqVTAEVitae Pharmaceuticals  St
NasdaqVTLVital Therapies, Inc.
NasdaqXBITXBiotech Inc.
NasdaqXNCRXencor, Inc.
NasdaqZGNXZogenix, Inc.

The Index is designed to track the performance of a set of securities listed on The Nasdaq Stock Market® (NASDAQ®) that are classified as either biotechnology or pharmaceutical according to the Industry Classification Benchmark (ICB).

As a result of the re-ranking, the following twelve securities will be removed from the Index:

NasdaqACRXAcelRx Pharmaceuticals, Inc.
NasdaqALIMAlimera Sciences Inc
NasdaqCLDNCelladon Corporation
NasdaqDYAXDyax Corp.
NasdaqPTXPernix Therapeutics Hldgs
NasdaqQLTIQLT Inc.
NasdaqSNTASynta Pharmaceuticals Corp.
NasdaqSVASinovac Biotech, Ltd
NasdaqVSTMVerastem, Inc.
NasdaqVVUSVivus, Inc.
NasdaqXOMAXOMA Corporation

About Nasdaq Global Indexes

Nasdaq Global Indexes has been creating innovative, market-leading, transparent indexes since 1971. Today, our index offering spans geographies and asset classes and includes diverse families such as the Dividend Achievers, Global, Nordic, Green Economy, Sharia and Commodity Indexes. We continuously offer new opportunities for financial product sponsors across a wide-spectrum of investable products and for asset managers to measure risk and performance. Nasdaq Global Indexes also provides custom index services and design solutions to selected financial organizations. For more information about Nasdaq Global Indexes, visit

Daily index values, weightings and historical data for Nasdaq indexes are available via Nasdaq Global Index Watch and Nasdaq Global Index Data Service.

About Nasdaq

Nasdaq (Nasdaq:NDAQ) is a leading provider of trading, clearing, exchange technology, listing, information and public company services across six continents. Through its diverse portfolio of solutions, Nasdaq enables customers to plan, optimize and execute their business vision with confidence, using proven technologies that provide transparency and insight for navigating today's global capital markets. As the creator of the world's first electronic stock market, its technology powers more than 70 marketplaces in 50 countries, and 1 in 10 of the world's securities transactions. Nasdaq is home to more than 3,600 listed companies with a market value of approximately $8.8 trillion and more than 10,000 corporate clients. To learn more, visit: or

The information contained above is provided for informational and educational purposes only, and nothing contained herein should be construed as investment advice, either on behalf of a particular financial product or an overall investment strategy. Neither The NASDAQ OMX Group, Inc. nor any of its affiliates makes any recommendation to buy or sell any financial product or any representation about the financial condition of any company or fund. Statements regarding Nasdaq’s proprietary indexes are not guarantees of future performance. Actual results may differ materially from those expressed or implied. Past performance is not indicative of future results. Investors should undertake their own due diligence and carefully evaluate companies before investing. ADVICE FROM A SECURITIES PROFESSIONAL IS STRONGLY ADVISED.


Media Contacts:
Peter Gau, Nasdaq
Will Briganti, Nasdaq

Issuer & Investor Contact:
Natasha Selzer, Nasdaq